Authors’ Response: Methodological Considerations Regarding the Use of Galectin-3 Expression Analysis in Preoperative Evaluation of Thyroid Nodules

Marek Niedziela, Eugeniusz Korman and Jaroslaw Maceluch

Department of Pediatric Endocrinology and Diabetes, Institute of Pediatrics (M.N., E.K.), Karol Marcinkowski University of Medical Sciences in Poznan, 60-572 Poznan, Poland; and Department of Gene Expression, Institute of Molecular Biology and Biotechnology (J.M.), University of Adam Mickiewicz, 60-572 Poznan, Poland

Address correspondence to: Marek Niedziela, Department of Pediatric Endocrinology and Diabetes, Institute of Pediatrics, Karol Marcinkowski University of Medical Sciences in Poznan, Szpitalna Street 27/33, 60-572 Poznan, Poland.

To the editor:

We are grateful to Professor Bartolazzi and his co-workers for their comments on our paper and will attempt to answer their pertinent queries. First, it was their previously published papers (1A 2A 3A ) that led us to investigate galectin-3 expression in our series of children with thyroid nodules. The aim of our study was to determine whether galectin-3 expression using the RT-PCR-based technique would improve the accuracy of preoperative diagnosis of thyroid carcinomas, because the results of fine-needle aspiration biopsies are not infallible.

We reported positive expression in proliferative forms of autoimmune thyroiditis and Hashimoto thyroiditis coexisting with a follicular adenoma (4A ). They say that these may be false-positive RT-PCR results.

The two important criticisms contained in the letter were, in our opinion, covered in our paper. First, we stated that the aim of our galectin-3 expression analysis was "to improve the classical cytological evaluation of the material obtained with ultrasound-guided biopsy," but importantly added that this technique was not the only diagnostic approach to be employed.

Secondly, they wonder whether some of the cells in the biopsy material are target cells for galectin-3 and, therefore, that false-positive results are possible in such cases. We disagree with their statement that our examination of galectin-3 expression was performed on "morphologically undefined cytological material" because we included a description of the representative cytological material obtained from biopsy, as shown in Table 1 of our paper (4A ).

Our data concerning galectin-3 expression in Hashimoto thyroiditis, based on the RT-PCR method, are in agreement with Herrmann et al. (5A ) who showed that "galectin-3 was also expressed focally and weakly in reactive follicular epithelium and entrapped follicles in chronic lymphocytic thyroidits." This paper was published precisely at the time our manuscript was being reviewed by JCEM experts. There are, however, a number of published papers supporting the possible false-positive expression of galectin-3, including those of Herrmann et al. (5A ) and of Beesley and McLaren (6A ), which are based on immunohistochemical analysis as well as those of Bernet et al. (7A ) and Martins et al. (8A ), based on the RT-PCR technique.

We therefore postulate that both RT-PCR and immunocytochemical diagnostic approaches performed preoperatively and RT-PCR and immunohistochemical analysis performed postoperatively on the same specimen would help in the phenotyping of target cells for galectin-3 and thereby answer the question as to whether a straight correlation exists between the two methods or not.

Finally, our paper does not disagree with their previously published findings (1A 2A 3A ) and even supports their usefulness in the preoperative detection of thyroid carcinoma. On the other hand, our paper may indicate some limitations in cases with pathogenetic and clinical diversity, such as Hashimoto thyroiditis and a solitary nodule. We want to stress that the preoperative expression of galectin-3 must be interpreted in such cases with great caution and only in parallel with routine conventional cytology, thereby improving it as a diagnostic or prognostic adjunct.

Received November 1, 2002.

References

  1. Gasbarri A, Martegani MP, Del Prete F, Lucante T, Natali PG, Bartolazzi A 1999 Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules. J Clin Oncol 17:3494–3502[Abstract/Free Full Text]
  2. Bartolazzi A 2000 Improving accuracy of cytology for nodular thyroid lesions. Lancet 355:1661–1662[CrossRef][Medline]
  3. Bartolazzi A, Gasbarri A, Papotti M, Bussolati G, Lucante T, Khan A, Inohara H, Marandino F, Orlandi F, Nardi F, Vecchione A, Tecce R, Larsson O; Thyroid Cancer Study Group 2001 Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 357:1644–1650[CrossRef][Medline]
  4. Niedziela M, Maceluch J, Korman E 2002 Galectin-3 is not an universal marker of malignancy in thyroid nodular disease in children and adolescents. J Clin Endocrinol Metab 87:4411–4415[Abstract/Free Full Text]
  5. Herrmann ME, LiVolsi VA, Pasha TL, Roberts SA, Wojcik EM, Baloch ZW 2002 Immunohistochemical expression of galectin-3 in benign and malignant thyroid lesions. Arch Pathol Lab Med 126:710–713[Medline]
  6. Beesley MF, McLaren KM 2002 Cytokeratin 19 and galectin-3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules. Histopathology 41:236–243[CrossRef][Medline]
  7. Bernet VJ, Anderson J, Vaishnav Y, Solomon B, Adair CF, Saji M, Burman KD, Burch HB, Ringel MD 2002 Determination of galectin-3 messenger ribonucleic acid overexpression in papillary thyroid cancer by quantitative reverse transcription-polymerase chain reaction. J Clin Endocrinol Metab 87:4792–4796[Abstract/Free Full Text]
  8. Martins L, Matsuo SE, Ebina KN, Kulcsar MA, Friguglietti CU, Kimura ET 2002 Galectin-3 messenger ribonucleic acid and protein are expressed in benign thyroid tumors. J Clin Endocrinol Metab 87:4806–4810[Abstract/Free Full Text]




This Article
Submit a related Letter to the Editor
Alert me when this article is cited
Alert me when eLetters are posted
Alert me if a correction is posted
Services
Email this article to a friend
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Request Copyright Permission
Google Scholar
Articles by Niedziela, M.
Articles by Maceluch, J.
Articles citing this Article
PubMed
PubMed Citation
Articles by Niedziela, M.
Articles by Maceluch, J.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals